ABCL - Abcellera Biologics Inc. (ABCL) CEO Carl Hansen on Q4 2021 Earnings Call Transcript

Abcellera Biologics, Inc. Q4 2021 Earnings Conference Call Feb 24, 2022 05:00 PM ET Company Participants Tryn Stimart - Chief Legal Officer, Chief Compliance Officer & Corporate Secretary Carl Hansen - President and CEO Andrew Booth - CFO Conference Call Participants Stephen Willey - Stifel Tiago Fauth - Credit Suisse Gary Nachman - BMO Capital Markets Puneet Souda - SVB Leerink Antonia Borovina - Bloom Burton Presentation Operator Ladies and gentlemen, thank you for standing by and welcome to the AbCellera Full Year 2021 Earnings Results and Business Update. At this time, all participants are in listen-only mode. Later, we will conduct a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being record. I would now like to turn the conference over to Tryn Stimart, Chief Legal and Compliance Officer. Please go ahead. Tryn Stimart Thank you. Good afternoon and welcome to AbCellera's full year 2021 business

For further details see:

Abcellera Biologics, Inc. (ABCL) CEO Carl Hansen on Q4 2021 Earnings Call Transcript